|
US5504074A
(en)
*
|
1993-08-06 |
1996-04-02 |
Children's Medical Center Corporation |
Estrogenic compounds as anti-angiogenic agents
|
|
US6908910B2
(en)
|
1993-08-06 |
2005-06-21 |
The Children's Medical Center Corporation |
Estrogenic compounds as anti-mitotic agents
|
|
US20040214807A1
(en)
*
|
1993-08-06 |
2004-10-28 |
D'amato Robert J. |
Estrogenic compounds as anti-mitotic agents
|
|
US6346510B1
(en)
*
|
1995-10-23 |
2002-02-12 |
The Children's Medical Center Corporation |
Therapeutic antiangiogenic endostatin compositions
|
|
EP0888310B1
(en)
*
|
1996-03-15 |
2005-09-07 |
AstraZeneca AB |
Cinnoline derivatives and use as medicine
|
|
GB9707800D0
(en)
|
1996-05-06 |
1997-06-04 |
Zeneca Ltd |
Chemical compounds
|
|
CN1252054C
(zh)
|
1996-09-25 |
2006-04-19 |
曾尼卡有限公司 |
抑制生长因子的作用的喹啉衍生物
|
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
|
EP1005470B1
(en)
|
1997-08-22 |
2007-08-01 |
AstraZeneca AB |
Oxindolylquinazoline derivatives as angiogenesis inhibitors
|
|
US20020002294A1
(en)
*
|
1997-09-24 |
2002-01-03 |
D' Amato Robert J. |
Estrogenic compounds as antiangiogenic agents
|
|
DE69942097D1
(de)
*
|
1998-08-11 |
2010-04-15 |
Novartis Ag |
Isochinoline derivate mit angiogenesis-hemmender wirkung
|
|
ATE371453T1
(de)
*
|
1998-08-13 |
2007-09-15 |
Novartis Pharma Gmbh |
Verfahren zur behandlung von okularen neovaskularen erkrankungen
|
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
|
PE20010306A1
(es)
*
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
US7141581B2
(en)
|
1999-07-02 |
2006-11-28 |
Agouron Pharmaceuticals, Inc. |
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
|
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
US6271233B1
(en)
|
1999-08-10 |
2001-08-07 |
Ciba Vision Corporation |
Method for treating ocular neovascular diseases
|
|
US7087592B1
(en)
*
|
1999-08-23 |
2006-08-08 |
Entre Med, Inc. |
Compositions comprising purified 2-methoxyestradiol and methods of producing same
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
UA72946C2
(uk)
|
1999-11-05 |
2005-05-16 |
Астразенека Аб |
Похідні хіназоліну як інгібітори васкулярного ендотеліального фактора росту (vegf)
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
BR0108085A
(pt)
|
2000-02-07 |
2003-03-18 |
Abbott Gmbh & Co Kg |
Derivados de 2-benzotiazolil uréia e seu uso como inibidores da cinase protéica
|
|
AU2001231710A1
(en)
|
2000-02-09 |
2001-08-20 |
Novartis Ag |
Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
|
|
JP2003525897A
(ja)
|
2000-03-06 |
2003-09-02 |
アストラゼネカ アクチボラグ |
治 療
|
|
GB0008269D0
(en)
*
|
2000-04-05 |
2000-05-24 |
Astrazeneca Ab |
Combination chemotherapy
|
|
US7160889B2
(en)
*
|
2000-04-07 |
2007-01-09 |
Astrazeneca Ab |
Quinazoline compounds
|
|
AU2001249865A1
(en)
|
2000-04-18 |
2001-10-30 |
Agouron Pharmaceuticals, Inc. |
Pyrazoles for inhibiting protein kinase
|
|
US7135581B2
(en)
*
|
2000-08-18 |
2006-11-14 |
Entremed, Inc. |
Antiangiogenic agents
|
|
US6995278B2
(en)
*
|
2000-08-18 |
2006-02-07 |
Entre Med, Inc. |
Antiangiogenic agents
|
|
DE60110802T2
(de)
|
2000-08-18 |
2005-10-06 |
Agouron Pharmaceuticals, Inc., San Diego |
Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen
|
|
US20050192258A1
(en)
*
|
2000-08-18 |
2005-09-01 |
Agoston Gregory E. |
Antiangiogenic agents
|
|
DE60140456D1
(de)
|
2000-09-01 |
2009-12-24 |
Novartis Vaccines & Diagnostic |
Aza heterocyclische derivate und ihre therapeutische verwendung
|
|
EA006711B1
(ru)
|
2000-09-11 |
2006-02-24 |
Чирон Корпорейшн |
Хинолиноновые производные в качестве ингибиторов тирозинкиназы
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
HN2002000156A
(es)
|
2001-07-06 |
2003-11-27 |
Inc Agouron Pharmaceuticals |
Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
|
|
AU2003209439A1
(en)
*
|
2002-01-30 |
2003-09-02 |
Entremed, Inc. |
Non-steroidal analogs of 2-methoxyestradiol
|
|
PL371486A1
(en)
|
2002-02-01 |
2005-06-13 |
Astrazeneca Ab |
Quinazoline compounds
|
|
UA77303C2
(en)
|
2002-06-14 |
2006-11-15 |
Pfizer |
Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use
|
|
EP2280003B1
(en)
|
2002-07-15 |
2014-04-02 |
Symphony Evolution, Inc. |
Process for preparing receptor-type kinase modulators
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
AU2003288899B2
(en)
|
2002-08-23 |
2009-09-03 |
Novartis Vaccines And Diagnostics, Inc. |
Benzimidazole quinolinones and uses thereof
|
|
RU2350618C2
(ru)
|
2002-11-04 |
2009-03-27 |
Астразенека Аб |
ПРОИЗВОДНЫЕ ХИНАЗОЛИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Src ТИРОЗИНКИНАЗЫ
|
|
US7268137B2
(en)
*
|
2002-11-07 |
2007-09-11 |
Campochiaro Peter A |
Ocular therapy
|
|
EP1565187A4
(en)
|
2002-11-13 |
2010-02-17 |
Novartis Vaccines & Diagnostic |
CANCER TREATMENT METHODS AND RELATED METHODS
|
|
NZ540340A
(en)
|
2002-12-19 |
2007-07-27 |
Pfizer |
2-(1H-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
|
|
US7371741B2
(en)
*
|
2003-05-28 |
2008-05-13 |
Entremed, Inc. |
Estradiol derivatives and pharmaceutical compositions using same
|
|
KR101471732B1
(ko)
|
2003-08-27 |
2014-12-16 |
옵쏘테크 코포레이션 |
안구의 혈관신생성 장애를 치료하기 위한 조합 치료법
|
|
MXPA06002296A
(es)
|
2003-08-29 |
2006-05-22 |
Pfizer |
Tienopiridina-fenilacetamidas y sus derivados utiles como nuevos agentes antiangiogenicos.
|
|
SI2213661T1
(sl)
*
|
2003-09-26 |
2011-11-30 |
Exelixis Inc |
c-Met modulatorji in postopki uporabe
|
|
AP2006003620A0
(en)
|
2003-10-15 |
2006-06-30 |
Osi Pharm Inc |
Imidazopyrazine tyroshine kinase inhibitors
|
|
WO2005046589A2
(en)
|
2003-11-07 |
2005-05-26 |
Chiron Corporation |
Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
|
|
AU2004293443A1
(en)
|
2003-11-19 |
2005-06-09 |
Signal Pharmaceuticals, Llc. |
Indazole Compounds and methods of use thereof as protein kinase inhibitors
|
|
BRPI0507891A
(pt)
|
2004-02-20 |
2007-07-24 |
Chiron Corp |
modulação dos processos inflamatório e metastático
|
|
US20070004689A1
(en)
*
|
2004-03-12 |
2007-01-04 |
Agoston Gregory E |
Antiangiogenic agents
|
|
AU2005222934B2
(en)
*
|
2004-03-12 |
2010-06-17 |
Entremed, Inc. |
Antiangiogenic agents
|
|
MXPA06011423A
(es)
|
2004-04-02 |
2007-01-23 |
Osi Pharm Inc |
Inhibidores de proteina cinasa heterobiciclica sustituida en el anillo 6,6-biciclico.
|
|
MY139689A
(en)
|
2004-07-20 |
2009-10-30 |
Osi Pharm Inc |
Imidazotriazines as protein kinase inhibitors
|
|
AU2005282721A1
(en)
*
|
2004-09-03 |
2006-03-16 |
Memory Pharmaceuticals Corporation |
4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
|
|
BRPI0518158A
(pt)
|
2004-10-14 |
2008-11-04 |
Hoffmann La Roche |
tiazolinonas de azaindol como agentes anti-cáncer
|
|
WO2006058298A2
(en)
*
|
2004-11-29 |
2006-06-01 |
Entremed, Inc. |
A method of administering anti-angiogenic agents and a method of treating disease using same
|
|
EP1833803A4
(en)
*
|
2005-01-03 |
2009-08-05 |
Myriad Genetics Inc |
PHARMACEUTICAL COMPOUNDS COMPRISING CASPASE ACTIVATORS AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
|
|
DOP2006000051A
(es)
|
2005-02-24 |
2006-08-31 |
Lilly Co Eli |
Inhibidores de vegf-r2 y métodos
|
|
US7304074B2
(en)
|
2005-04-05 |
2007-12-04 |
Hoffmann-La Roche Inc. |
Substituted 1,5-naphthyridine azolinones
|
|
WO2006124996A2
(en)
*
|
2005-05-17 |
2006-11-23 |
Supergen, Inc. |
Inhibitors of polo-like kinase-1
|
|
AU2006247062A1
(en)
|
2005-05-17 |
2006-11-23 |
Novartis Ag |
Methods for synthesizing heterocyclic compounds
|
|
KR101368519B1
(ko)
|
2005-05-23 |
2014-02-27 |
노파르티스 아게 |
결정형 및 기타 형태의 4-아미노-5-플루오로-3-［6-(4-메틸피페라진-1-일)-1ｈ-벤즈이미다졸-2-일］-1ｈ-퀴놀린-2-온 락트산염
|
|
US7566721B2
(en)
*
|
2005-08-08 |
2009-07-28 |
Osi Pharmaceuticals, Inc. |
Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
|
|
US20070185069A1
(en)
*
|
2005-11-14 |
2007-08-09 |
Plum Stacy M |
Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
|
|
EP1957074B1
(en)
|
2005-11-29 |
2014-03-19 |
Novartis AG |
Formulations of quinolinones
|
|
AR057960A1
(es)
|
2005-12-02 |
2007-12-26 |
Osi Pharm Inc |
Inhibidores de proteina quinasa biciclicos
|
|
US8575164B2
(en)
*
|
2005-12-19 |
2013-11-05 |
OSI Pharmaceuticals, LLC |
Combination cancer therapy
|
|
US20070176403A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Dennis Calderone |
Air adjustable seat
|
|
AU2007227256B2
(en)
*
|
2006-03-20 |
2012-10-04 |
Entremed, Inc. |
Disease modifying anti-arthritic activity of 2-methoxyestradiol
|
|
US20070258976A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Ward Keith W |
Combination Therapy for Diseases Involving Angiogenesis
|
|
WO2008094665A1
(en)
*
|
2007-01-31 |
2008-08-07 |
Entremed, Inc. |
Method of treating amyloidosis mediated diseases
|
|
US20080190689A1
(en)
*
|
2007-02-12 |
2008-08-14 |
Ballard Ebbin C |
Inserts for engine exhaust systems
|
|
EP2250173A1
(en)
*
|
2008-01-18 |
2010-11-17 |
OSI Pharmaceuticals, Inc. |
Imidazopyrazinol derivatives for the treatment of cancers
|
|
JP2011520970A
(ja)
*
|
2008-05-19 |
2011-07-21 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
置換されたイミダゾピラジン類およびイミダゾトリアジン類
|
|
EP2387563B2
(en)
|
2009-01-16 |
2022-04-27 |
Exelixis, Inc. |
Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quinolin-4-yl]oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
|
|
CA2752826A1
(en)
|
2009-04-20 |
2010-10-28 |
OSI Pharmaceuticals, LLC |
Preparation of c-pyrazine-methylamines
|
|
JP2012526138A
(ja)
*
|
2009-05-07 |
2012-10-25 |
オーエスアイ・ファーマシューティカルズ，エルエルシー |
副腎皮質癌を治療するためのｏｓｉ−９０６の使用
|
|
UA108618C2
(uk)
|
2009-08-07 |
2015-05-25 |
|
Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
|
|
US20110189174A1
(en)
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
|
US10968290B2
(en)
|
2017-03-28 |
2021-04-06 |
Exxonmobil Chemical Patents Inc. |
Metallocene-catalyzed polyalpha-olefins
|
|
US11021553B2
(en)
|
2018-02-12 |
2021-06-01 |
Exxonmobil Chemical Patents Inc. |
Metallocene dimer selective catalysts and processes to produce poly alpha-olefin dimers
|
|
US11078308B2
(en)
|
2018-02-12 |
2021-08-03 |
Exxonmobil Chemical Patents Inc. |
Processes to produce poly alpha-olefin trimers
|
|
EP3752540A4
(en)
|
2018-02-12 |
2021-12-01 |
ExxonMobil Chemical Patents Inc. |
CATALYST SYSTEMS AND PROCESSES FOR POLY ALPHA-OLEFIN WITH HIGH VINYLIDENE CONTENT
|
|
WO2019210030A1
(en)
|
2018-04-26 |
2019-10-31 |
Exxonmobil Chemical Patents Inc. |
Non-coordinating anion type activators containing cation having branched alkyl groups
|
|
US11059791B2
(en)
|
2019-04-25 |
2021-07-13 |
Exxonmobil Chemical Patents Inc. |
Non-coordinating anion type benzimidazolium activators
|
|
CN112694474B
(zh)
*
|
2019-10-23 |
2022-03-18 |
四川大学 |
吲唑类衍生物及其制备方法和用途
|
|
CN114845980A
(zh)
|
2019-10-28 |
2022-08-02 |
埃克森美孚化学专利公司 |
二聚物选择性金属茂催化剂、非芳族烃可溶性活化剂和用其制备聚α-烯烃低聚物的方法
|
|
US11572423B2
(en)
|
2019-12-11 |
2023-02-07 |
Exxonmobil Chemicals Patents Inc. |
Processes for introduction of liquid activators in olefin polymerization reactions
|
|
US11584707B2
(en)
|
2019-12-16 |
2023-02-21 |
Exxonmobil Chemical Patents Inc. |
Non-coordinating anion type activators containing cation having aryldiamine groups and uses thereof
|
|
CN115485311A
(zh)
|
2020-02-24 |
2022-12-16 |
埃克森美孚化学专利公司 |
用于生产乙烯叉基封端的聚α-烯烃的柄型-双(茚-2-基)催化剂
|
|
US11746163B2
(en)
|
2021-01-05 |
2023-09-05 |
Exxonmobil Chemical Patents Inc. |
Isohexane-soluble unsaturated alkyl anilinium tetrakis(perfluoroaryl)borate activators
|
